[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[AKRO](/topic/akro)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:akro/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/akro/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% no change  
**1 Month**: XX% +6%  
**6 Months**: XX% -X%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2025-08-04  
**1-Year Low**: XX% on 2025-03-30  

**Most Supportive Themes**
- **Positive Sentiment and MASH Focus:** (55%) Positive sentiment is high, with XX% of mentions being positive, and the company's focus on MASH treatment is generating interest.
- **High Social Media Engagement:** (35%) Mentions of AKRO are frequent across multiple social media platforms, with high engagement on TikTok and X.
  
**Most Critical Themes**
- **Mixed Trial Results:** (1%)  Concerns about mixed results from the IMPACT trial of pemvidutide in MASH are being discussed.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %  | Negative | %  |
| ------- | -------- | -  | ------- | -  | -------- | -  |
| Reddit  | XX       | X% | X       | X% |          |    |
| TikTok  | XX       | X% | XX      | X% | XX       | X% |
| X       | X        | X% | XX      | X% | XX       | X% |
| YouTube | XX       | X% | X       | X% |          |    |
|         |          |    |         |    |          |    |
| Total   | XXX      | X% | XXX     | X% | XX       | X% |